Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
July 24, 2019
Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction
Katharina A Mayer, Johannes Stöckl, Gerhard J Zlabinger, et al.
Immunity, Inflammation and Disease
|
October 31, 2020
Cesarean section and risk of allergies in Ecuadorian children: A cross-sectional study
Amélie Gorris, Gabriela Bustamante, Katharina A Mayer, et al.
Expert Opinion on Emerging Drugs
|
June 18, 2022
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials
Katharina A Mayer, Klemens Budde, Bernd Jilma, et al.
Current Opinion in Organ Transplantation
|
December 14, 2020
New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment
Katharina A Mayer, Konstantin Doberer, Farsad Eskandary, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
May 30, 2025
Targeting CD38 in Antibody-Mediated Rejection
Katharina A Mayer, Klemens Budde, Matthias Diebold, et al.
Transplantation
|
August 28, 2024
Chronic Rejection After Kidney Transplantation
Matthias Diebold, Katharina A Mayer, Luis Hidalgo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 6, 2016
The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation
Guido A Gualdoni, Katharina A Mayer, Lisa Göschl, et al.
Kidney International
|
April 20, 2025
Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients
Klemens Budde, Bilgin Osmanodja, Eva Schrezenmeier, et al.
Expert Opinion on Investigational Drugs
|
February 10, 2025
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation
Katharina A Mayer, Klemens Budde, Martina Schatzl, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 3, 2024
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional Decline
Carsten T Herz, Matthias Diebold, Alexander Kainz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
July 24, 2019
Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction
Katharina A Mayer, Johannes Stöckl, Gerhard J Zlabinger, et al.
Immunity, Inflammation and Disease
|
October 31, 2020
Cesarean section and risk of allergies in Ecuadorian children: A cross-sectional study
Amélie Gorris, Gabriela Bustamante, Katharina A Mayer, et al.
Expert Opinion on Emerging Drugs
|
June 18, 2022
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials
Katharina A Mayer, Klemens Budde, Bernd Jilma, et al.
Current Opinion in Organ Transplantation
|
December 14, 2020
New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment
Katharina A Mayer, Konstantin Doberer, Farsad Eskandary, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
May 30, 2025
Targeting CD38 in Antibody-Mediated Rejection
Katharina A Mayer, Klemens Budde, Matthias Diebold, et al.
Transplantation
|
August 28, 2024
Chronic Rejection After Kidney Transplantation
Matthias Diebold, Katharina A Mayer, Luis Hidalgo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 6, 2016
The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation
Guido A Gualdoni, Katharina A Mayer, Lisa Göschl, et al.
Kidney International
|
April 20, 2025
Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients
Klemens Budde, Bilgin Osmanodja, Eva Schrezenmeier, et al.
Expert Opinion on Investigational Drugs
|
February 10, 2025
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation
Katharina A Mayer, Klemens Budde, Martina Schatzl, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 3, 2024
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional Decline
Carsten T Herz, Matthias Diebold, Alexander Kainz, et al.
Page
of 3